SanaCurrents Probability Sentiment

//SanaCurrents Probability Sentiment

ADMA New Catalysts For 2019 – Two PDUFA decisions on immunodeficiency therapies

By | 2019-01-22T10:10:21-04:00 January 22nd, 2019|Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|

SUMMARY SanaCurrents assigns a pivotal sentiment the FDA will approve [...]

Cara Therapeutics (CARA) Q1 2019 Catalyst: Phase III efficacy trial, KALM-2

By | 2019-01-22T10:10:46-04:00 January 2nd, 2019|Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment|

SUMMARY Sana Currents assigns a pivotal sentiment that Cara Therapeutics [...]

ADMA Biologics (NASDAQ:ADMA) December Catalyst: PDUFA for BIVIGAM

By | 2019-01-22T10:02:45-04:00 December 13th, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

SanaCurrents assigns a pivotal sentiment the FDA will approve the [...]

Hemophilia Treatment Company Catalyst Biosciences’ Antibody Update May Catalyze Shares

By | 2019-01-22T10:03:35-04:00 December 12th, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Insights, Insights-Home, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

Catalyst Biosciences, Inc. (NASDAQ:CBIO) , a company that is developing improved [...]

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) – 3Q 2019 catalyst, CBD treatment for Fragile X

By | 2019-01-22T10:03:50-04:00 November 21st, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

3Q ‘19 catalyst, CBD treatment for Fragile X SanaCurrents is [...]

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) – December Catalyst, Lymphoma Phase IIb Trial

By | 2019-01-22T10:03:59-04:00 November 21st, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

December catalyst, lymphoma phase IIb trial SanaCurrents assigns a pivotal [...]

Galmed (GLMD) – November Catalyst: Aramchol

By | 2019-01-22T10:04:09-04:00 November 6th, 2018|Bill Langbein, Health Care Equipment & Services, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Probability Sentiment|

November Catalyst: Aramchol SanaCurrents forecasts an advantageous probability Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) [...]

SSL